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Matthew J. Deeths1, Bart T. Endrizzi1, Michelle L. Irvin1, Lynne P. Steiner1, Marna E. Ericson1 and
Maria K. Hordinsky1
This study demonstrates the feasibility and efficacy of using flow cytometric analysis with intracellular cytokine
staining for characterization of T-cell phenotype and functional status in extensive alopecia areata (EAA) scalp
skin. Cell suspensions were made from scalp punch biopsies taken from 12 patients with long-standing EAA
(average disease duration 14 years, 95% hair loss) and six control subjects. EAA samples had a lower percentage
of CD-3-expressing cells, but CD-4/CD-8 ratios remained similar to controls. Expression of CD-69 was found
only in EAA scalp biopsies, suggesting that T-cells from EAA scalp have undergone activation. No difference was
found in tumor necrosis factor a expression. Surprisingly, EAA scalp T-cells produced less IL-2 and CD-8 T-cells
produced less IFN-g. Immunohistochemical staining of formalin-fixed paraffin-embedded specimens demon-
strated that IFN-g-producing cells in EAA scalp were not greater in number than in normal specimens. The few
identified IFN-g-producing cells demonstrated no tendency to localize to the perifollicular region, and were
similarly distributed as in control specimens. The abnormalities in cytokine production may explain the relative
paucity of inflammatory change observed in the clinical setting and suggest that T-cell responses in EAA scalp
are tightly, albeit aberrantly, regulated via mechanisms of peripheral T-cell tolerance.
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INTRODUCTION
Alopecia areata (AA) and its more severe variants are
characterized clinically by nonscarring and potentially
reversible hair loss. The disease is postulated to be an
organ-specific autoimmune disease with data suggesting
melanocyte antigens as the immune targets (Gilhar et al.,
2001). Several lines of evidence suggest that the hair loss that
occurs in patients with AA may be mediated by aberrant
T-cell responses. T-cells constitute the major component of
peribulbar infiltrates observed in acute AA, implying that
these cells are important in the pathophysiology of the
disease (Baadsgaard et al., 1987; Sperling and Lupton, 1995;
Ghersetich et al., 1996). Studies have shown these infiltrating
T-cells to be oligoclonal and autoreactive (Kalish et al., 1992;
Dressel et al., 1997). Perhaps, most convincing is that T-cells
purified from scalp skin of patients with AA stimulated with
follicular homogenate will induce disease in scalp explants in
a severe combined immunodeficiency mouse. In this model,
the grafted follicles grow hair with T-cell infiltrate resolution
(Gilhar et al., 1998, 2003).
Previous studies have shown that cytokines derived from
immune cells (including T-cells) may be found in AA as well
as normal scalp specimens. Some studies suggest that certain
AA treatments may function by altering levels of cytokines
in the scalp (Perret et al., 1990; Hoffmann et al., 1996).
Nonetheless, AA differs markedly from other inflammatory
diseases of the scalp such as tinea capitus, or discoid lupus
erythematosus, because in AA, hair follicles are not generally
destroyed by the inflammatory response and regrowth
typically occurs (Mitchell and Krull, 1984).
The hypothesis of immune privilege and loss of immune
privilege in AA has been supported by studies of proximal
follicular major histocompatibility complex expression (Paus
et al., 1999). Expression of major histocompatibility complex
class I and class II on follicular epithelial cells is induced by
stimulation with IFN-g (Gilhar et al., 1993, 2003). Most
recently, Gilhar et al. (2005) used the C3H/HeJ mouse model
of AA to demonstrate induction of AA with the administration
of IFN-g. This induction of AA coincided with the develop-
ment of para- and intrafollicular infiltrate. These studies have
provided conclusive evidence for the role of IFN-g and
immune system induction in the development of AA. The
presence and role of IFN-g in long-standing extensive
alopecia areata (EAA) has yet to be demonstrated.
In this study, we demonstrate that T-cells present in scalp
biopsy specimens from patients with EAA are activated
(expressing CD-69) and in a state of partial tolerance, with
respect to their ability to produce the autocrine growth factor
IL-2 and the effector cytokine IFN-g. We further demonstrate
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that the remaining IFN-g-producing cells in long-standing
EAA scalp biopsy specimens are similar in number and
distribution to patterns seen in scalp biopsy specimens taken
from normal control scalp.
RESULTS
Inflammation in the AA scalp biopsy samples was assessed in
a blinded manner. Peribulbar and perivascular as well as
inflammation in the bulge region was assessed as either mild,
moderate, or severe. Two patients were classified as having
moderate peribulbar inflammation, six had mild-to-moderate
inflammation, and the remainder had mild peribulbar
inflammation. Ten patients had mild inflammation around
the bulge region and two had moderate inflammation. Three
patients had mild-to-moderate perivascular inflammation;
the remainder had mild perivascular inflammation. Based on
the histopathological data, all patients had active disease
(Steiner L.P. et al. (2002) Poster Presentation, Fourth Inter-
national Alopecia Areata Research Workshop, Washington,
DC, November).
It is difficult to distinguish small viable lymphocytes in
scalp biopsy digests from contaminating red blood cells and
keratinocytes using forward- and side-light scatter character-
istics alone. Keratinocytes overlap substantially with similar-
sized lymphocytes and outnumber these cells to such an
extent that even minimal overlap between the groups results
in significant contamination of the lymphocyte ‘‘gate’’ with
these highly autofluorescent and nonspecifically staining
keratinocytes (Figure 1a). Thus, events initially gated using
forward- and side-light scatter are further gated, to filter out
contaminating keratinocytes, using a T-cell-specific CD-3
stain (Figure 1b). This results in a homogeneous population
of double-gated cells, which when back-graphed onto the
forward- and side-light scatter fall within a region identical
to that seen with control lymphocytes (Figure 1c). This
population is defined as T-cells for the purpose of all
additional analysis described here. CD-4 expression by
T-cells is shown in Figure 1d for one representative EAA
patient. ‘‘Fat cells’’ present in the skin biopsy specimens have
been suggested as affecting flow cytometry data. Whether
triglycerides, fatty acids, or micelles interfered with the flow
cytometry process is not known, but our supposition is that
the gating technique we used on all the samples was reliable
and that any effect of ‘‘fat cells’’ was negligible.
As cytokines produced by activated lymphocytes are
immediately released, it is not possible to detect these
proteins intracellularly in the absence of agents used to block
their secretion. As these agents cannot be used in vivo, T-cells
were activated in the presence of phorbol 12-myristate
13-acetate/ionomycin (as a surrogate for antigen exposure)
and monensin (to block cytokine secretion) for 4 hours
immediately ex vivo. It is assumed that the cytokine
expression pattern after this very short in vivo incubation
recapitulates what should occur in vivo upon antigen-specific
activation of these cells. IL-2 expression data, along with the
gating scheme for the data, are shown for one EAA scalp skin
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Figure 1. An example of one scalp biopsy analysis using dual laser flow
cytometry. (a) Scatter plot demonstrates the lymphocyte gate with
lymphocytes identified based on forward- and side-light scatter
characteristics. (b) A T-cell-specific CD-3 stain is used to further gate out
contaminating cells and to define the lymphocyte population. (c) Double-
gated and back-graphed scatter plot identifies a homogeneous population of
T-cells that falls into the region identical to that seen with control
lymphocytes, and (d) stains with a bimodal distribution using anti-CD-4
antibody.
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Figure 2. T-cell lL-2 expression in EAA scalp. (a) Scatter plot showing
CD-8 and lL-2 expression on T-cells. Histograms showing IL-2 expression
by (b) CD-8-positive and (c) CD-8-negative T-cells.
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Figure 3. IFN-c expression measured in cells stained as in Figure 2.
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biopsy specimen in Figure 2a–c. IFN-g expression data for one
EAA scalp skin biopsy specimen are presented in Figure 3a.
As has been previously shown for T-cells from other sites
(Picker et al., 1995), activation of T-cells from scalp with
phorbol 12-myristate 13-acetate/ionomycin results in down-
regulation of CD-4 expression on helper T-cells. This effect is
exaggerated in the presence of monensin, which blocks CD-4
re-expression (data not shown). Cells were stained for CD-4
and CD-69 in order to determine the helper/suppressor
cytotoxic ratio and the prevalence of cells that are exposed to
antigen recently in vivo, and CD-8 expression was used to
delineate T-cell subsets when performing cytokine analysis
on in vitro-stimulated cells. This protocol also provided an
internal control for T-cell subset delineation. In all cases, the
helper/suppressor cytotoxic ratio was virtually identical when
using either CD-4 or CD-8 stain.
The absolute percent of isolated cells that expressed CD-3
in EAA scalp is less than that found in isolated cells of the
control scalp (Figure 4a). These values represent gate 3 as a
percent of total events recorded using flow cytometry, and
roughly correlate to the ratio of CD-3 T-cells to the remainder
of isolated cells not staining with CD-3. The CD-3-negative
cells include keratinocytes, dermal fibroblasts, red blood
cells, as well as other miscellaneous inflammatory cells, all of
which were not independently counted in our experimental
analyses. Concurrently, EAA scalp biopsy specimens also
routinely yielded fewer total cell counts than the control
specimens. Analysis of the EAA histopathologic samples
revealed miniaturization of follicles (data not shown), which
could account for the cell count isolation discrepancy.
Despite the differences in total cell counts and percent
T-cells, no difference in CD-4/CD-8 T-cell distribution
between EAA and control scalp was found (Figure 4b).
Activation-induced molecule, also known as CD-69, is
upregulated within hours of T-cell receptor binding to high-
affinity ligand, and is rapidly downregulated with the loss of
this binding. Thus, CD-69 is a marker for recent activation of
T-cells in vivo (Ziegler et al., 1994; Fernandez-Herrera et al.,
1996). Figure 5a is representative of CD-69 expression for the
EAA subjects examined. CD-69 expression for EAA subjects
was elevated to a similar level for T-cells that express CD-4
and T-cells that lack CD-4 (CD-8 T-cells) (Figure 5b). A lower
percentage of T-cells from four normal control subjects were
elevated for CD-69 expression compared to the EAA patients.
Only four control subjects were studied with this antibody
(data not shown). The high level of CD-69 expression by
EAA scalp T-cells indicates that these cells have recently
been exposed to antigen, most probably in the scalp of these
patients, who clinically have no hair.
The percentage of T-lymphocytes expressing tumor
necrosis factor a in control scalp biopsy specimens tended
to be higher than in EAA scalp biopsies in both subsets of
T-cells. However, we noted substantial variability in the
expression of this cytokine, especially in EAA patients (Figure
6b). None of the control scalp or EAA scalp T-cells expressed
the T-helper (Th)-2 cytokine IL-4. These negative results are
not presented.
IL-2 production was seen in a higher percentage of CD-8
cells from control versus EAA scalp. This difference was not
as pronounced in the CD-4 subset of T-cells (Figure 6b).
However, in the CD-8 subset, even control cells expressed a
low percentage of IL-2. This likely reflects normal phenotypic
differences between the subsets of T-cells (Deeths et al.,
1999).
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Figure 4. Summary of CD-3 and CD-4 staining of scalp T-cells in control and
EAA patients. (a) The percentages of CD-3-positive T-cells in EAA scalp
specimens are fewer than seen in control scalp specimens; however, (b) the
T-cell subset distribution is the same in both the groups.
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Figure 5. CD-69 expression in T-cells from EAA scalp suggests recent
antigen exposure. (a) Histogram showing CD-69 staining (heavy line) and
isotope control staining (light line) in CD-3-gated T-cells from EAA scalp.
(b) CD-69 expression is similar for CD-4 and non-CD-4 cells.
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IFN-g production was minimal in CD-4 helper T-cells from
both control and EAA scalp (Figure 6a). However, in the
CD-8 subset, about 50% of control scalp cells produced
IFN-g. The percent of CD-8 cells expressing high levels of
IFN-g in individual EAA patients showed more variation than
it did in control subjects, but the trend was toward a decrease
on average (Figure 6a). We found no difference (clinically
or with respect to expression of other cytokines) between the
two patients with high IFN-g shown in Figure 6a and the other
patients who had less than 30% of CD-8 cells positive for this
cytokine. The data on these two patients do substantially
skew the mean for this group.
To assess the localization of IFN-g-producing cells in EAA,
we used a polyclonal anti-human IFN-g antibody for
histochemical staining of sections from EAA scalp biopsy
specimens. Positive staining for IFN-g expression was
obtained from lymph node biopsy specimens after lympho-
cyte activation and proliferation secondary to viral infection
in rhesus macaque monkeys, which had received an
intravaginal inoculation of simian immunodeficiency virus.
Analysis of these sections demonstrated a correlation
between IFN-g production and the increase in viral replica-
tion in the lymph node, and is considered to be a positive
control for changes in IFN-g levels (Figure 7, top panel).
Negative control comparison was obtained from scalp biopsy
samples from five patients without EAA or other inflammatory
skin conditions. These specimens were stained and analyzed
in conjunction with the patient samples.
Scalp punch biopsy specimens from patients with long-
standing EAA were fixed and embedded in paraffin, similar to
the control samples. Horizontal sections from these samples
were stained for IFN-g expression along with the positive
and negative controls. Our results demonstrate no significant
IFN-g expression in long-standing EAA above that seen in
the normal control scalp biopsies (Figure 7, lower panel). The
few scattered IFN-g-producing cells detected in the long-
standing EAA biopsies were similar in number and distribu-
tion to the control biopsies, being found in the interstitial
connective tissue of the biopsy specimen. The IFN-g-
producing cells in both the controls and patients did not
show a propensity for localizing to the perifollicular regions.
Thus, IFN-g expression does not appear to be maintained
in long-standing EAA.
DISCUSSION
The role of T-cell-mediated immunity in long-standing EAA is
still being defined. Results by several groups have shown
expression of cytokine mRNA important in inflammation
in EAA scalp (Hoffmann et al., 1996; Bodemer et al., 2000).
However, these studies do not identify the cells responsible
for expression of these inflammatory mediators and do not
demonstrate expression of actual protein mediators. Data
on cytokine expression in animal models suggest that the
cytokine expression profile in chronic AA mouse skin does
not demonstrate an unequivocal Th-1 versus Th-2 cytokine
dominant state (McElwee et al., 2002). In other experiments,
Th-1- and Th-2-associated cytokines were compared in
sham-grafted mice, AA-affected mice, skin-grafted mice that
did not develop AA, and nonsurgically manipulated controls.
AA-affected mice were found to demonstrate increased
expression in all cytokines evaluated, whereas mice with
resistance to AA had significantly higher expression levels of
cytokines IL-4 and IL-10 but no increases in proinflammatory
cytokines IL-6 or IL-12 (McElwee et al., 2002). In human
studies, the phenotype of cloned human T-cells was
examined (Kalish et al., 1992), but these studies are limited
in their ability to describe the phenotype of T-cells in vivo.
The data presented here thus expand on previous work in
both human and mouse systems by describing the phenotype
of T-cells in scalp biopsy specimens from patients with
extensive alopecia of long-standing duration (average 14
years) immediately ex vivo.
The lower absolute percentage of CD-3 T-cells in patients
with EAA of long-standing duration is in conflict with the
expectation that scalp biopsy samples from patients with AA
have a higher number of inflammatory cells. Our gating
technique as described should have eliminated significant
contamination by keratinocytes. Other cells such as mono-
cytes, fibroblasts, and red blood cells would not have stained
with CD-3. Perhaps, it is only in patients with early active
disease that the numbers of inflammatory cells are increased,
CD8– IFN-γ production
CD8– IL-2 production
CD8– TNF- production CD8+ TNF- production
CD8+ IL-2 production
CD8+ IFN-γ production
%
 IF
N-
γ 
%
 IL
-2
 
%
 T
N
F-

 
%
 T
N
F-

%
 IL
-2
%
 IF
N
-γ
 
60
50
40
30
20
10
0
50
40
30
20
10
0
80
60
40
20
0
80
60
40
20
0
50
40
30
20
10
0
60
50
40
30
20
10
0
P = 0.54
P = 0.003
P = 0.11 P = 0.09
P = 0.07
P = 0.04
Controls Subjects Controls Subjects
Controls Subjects
Controls Subjects
Controls Subjects
Controls Subjects
a
b
c
Figure 6. Cytokine expression phenotype of scalp T-cells from 12 EAA
patients and six controls. The CD-8-negative helper T-cell production of
IFN-g was minimal in both control and EAA (P¼ 0.54) scalp biopsy
specimens. (a) The percentage of EAA CD-8 cells producing IFN-g showed
more variation than control subjects (P¼0.04), but was decreased on
average. The CD-8-negative T-cell production of IL-2 was higher in controls
compared to EAA scalp biopsy specimens (P¼ 0.003). (b) The CD-8-positive
T-cell production of IL-2 was comparable between controls and EAA
(P¼0.07) scalp biopsy specimens. (c) The CD-8 (P¼0.09) and non-CD-8
T-cell (P¼0.11) production of tumor necrosis factor a (TNF-a) was higher in
control scalp biopsy specimens compared to EAA scalp biopsy specimens, but
these differences were not statistically significant.
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and that in patients with long-standing extensive disease, the
total numbers may actually be less in scalp skin. Our data
suggest the possibility that EAA scalp is not consistently
characterized by an overall increase in CD-3 T-cells. Since
this is the first time that human scalp biopsy samples from
patients with EAA of long-standing duration have been
studied using the techniques described, it may be that the
findings are representative of this type of AA. The miniatur-
ized hair follicle, as compared to an anagen hair follicle in
the acute phase of AA, may have peribulbar inflammation,
but perhaps the total number of T-cells per hair bulb we
observed reflects the homogeneous reduction in hair follicle
size in EAA of long duration. This idea deserves further study.
Histologic evaluations of AA scalp biopsy specimens
(Ranki et al., 1984; Sperling and Lupton, 1995; Whiting,
2001) in AA lesions of long-standing duration demonstrate a
paucity of peribulbar inflammation. This is in contrast to
normal scalp skin that usually shows a mild inflammatory
infiltrate around the infundibulum (D. Whiting, personal
communication) and probably represents a response to
the hair follicle microenvironment. Perhaps, the paucity of
peribulbar inflammation in these patients with chronic long-
standing EAA can be attributed to a defect in the ability of
these cells to produce autocrine growth factors such as IL-2
(Figure 6b). This might in turn account for the decreased
number of T-cells observed in AA scalp biopsy specimens
taken from patients with long-standing disease where
lymphocytes are primarily found around small vellus hair
bulbs in the papillary dermis (Whiting, 2003).
The defect in cytokine production we have observed in
T-cells from EAA scalp is not limited to IL-2. Likewise, there
could be a direct association between decreased inflamma-
tion and alterations in cytokine production. It should be
noted that in many instances it has been shown that T-cells in
peripheral tissues, like the skin, neither require IL-2 for
survival nor produce IL-2 in response to antigen. However, it
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Figure 7. Immunohistochemical staining for IFN-c with a peroxidase assay (brown) and hematoxylin nuclear staining (blue). (Upper panel) On days 3, 7, and
12 post-transvaginal inoculation of SIV virus, draining lymph nodes were harvested and fixed. These samples were then embedded in paraffin and 5–6 mm
sections were taken for immunohistochemical staining. Images (original magnification:  4 and  20) are presented for each time point. The sample on day 12
is a positive control for immune cell production of IFN-g. (Lower panel) Four-millimeter punch biopsy specimens from the parietal scalp were fixed with 8%
paraformaldehyde, paraffin-embedded, and stained for IFN-g expression with the same methodology used for the positive control in the upper panel. Control
scalp biopsy data are on the left; three sample pairs from EAA subjects are on the right. No significant IFN-g expression was observed in either the control or
subject biopsy specimens. Also, there was no propensity for IFN-g expression localizing around hair follicles. All sections were visualized at original
magnification:  4 (bar¼250 mm) and original magnification:  20 (bar¼ 50 m).
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seems unlikely that this defect is a result of complete
destruction of antigen driving the immune response because,
as based on CD-69 expression, there is evidence that some
cells have been exposed to an activating antigen in vivo.
The results presented here show that antigen-specific scalp
T-cells from EAA patients are not Th-2 polarized, and appear
to have some intrinsic defect in the production of the Th-1
cytokines IFN-g and IL-2. Furthermore, the remaining
IFN-g-producing cells in EAA do not localize to the
perifollicular site, and appear to be in number similar to that
found in normal skin biopsies. Future analysis of serum and
tissue levels of IFN-g in EAA and comparison of IFN-g
expression in the acute development of AA with that
identified in our studies may yield further insight into the
role of IFN-g in long-standing EAA.
One hypothesis to explain the diminished cytokine
production is to suggest that there is a state of partial
tolerance or immune deviation in the skin of patients with
EAA. This notion coincides with the finding that the
inflammatory response in long-standing EAA is limited such
that scarring and follicle destruction typically do not occur.
Furthermore, our results suggest that T-cells from scalp
specimens taken from patients with EAA are specific for
and activated by antigen present in the skin, further
supporting the concept that T-cell responses in EAA scalp
are tightly, albeit aberrantly, regulated by mechanisms of
peripheral T-cell tolerance.
Recent studies support the idea that the immune environ-
ment of the hair follicle is unique (Christoph et al., 2000).
The mechanisms regulating T-cell immunity in EAA are most
likely numerous, but may include activation-induced non-
responsiveness (Deeths et al., 1999), anergy (Mueller and
Jenkins, 1995), and/or activation-induced cell death (Russell,
1995). If indeed some mechanisms of T-cell tolerance
continue to operate within the context of EAA, there is an
opportunity to exploit these mechanisms in treating patients
with EAA of long-standing duration.
MATERIALS AND METHODS
Subjects
This study was conducted according to the Declaration of Helsinki
Principles and was reviewed and approved by the Human Subjects
Committee, Institutional Review Board, of the University of
Minnesota. We compared data from 12 Caucasian patients (five
men, seven women, aged 30–68 years) with EAA (greater than 95%
scalp hair loss) with data obtained from six normal control subjects
(three men, three women). Patients were classified according to the
Alopecia Areata Guidelines and all had greater than 95% scalp hair
loss (Olsen et al., 2004). Therefore, using the guidelines classifica-
tion system, patients were labeled as either S4 (76–99% scalp hair
loss) or S5 (100% scalp hair loss). Any hair present on patients’
scalps was either white nonpigmented terminal, indeterminate, or
vellus type. When enough hair fibers were present, hair pull tests
were performed. No positive pull tests were documented in this
group of patients. Subjects gave their written informed consent, were
ambulatory, and in good physical and emotional health. Subjects
were excluded if they had used tanning beds or psoralen and UVA
light therapy for 2 months prior to study entry. Subjects were also
excluded if they had used topical or systemic glucocorticoids,
progesterone, androgen, or antiandrogen drugs, FK506, cyclospor-
ine, immunotherapy with dinitrochlorobenzene, squaric acid dibutyl
ester, or diphenyl cyclopropenone, within 6 months of study entry.
Patients were accepted if they had been on stable doses of thyroid or
estrogen replacement within 6 months of the study initiation.
Subjects with a past medical history of any condition that could
confound the results of the study, including drug or alcohol abuse,
were excluded, as were pregnant or nursing women. Subjects were
asked to refrain from using any topical scalp medication within
6 weeks of study entry. Subjects were asked to shampoo their scalp
with free and clear shampoo daily, starting 5 days prior to study
initiation. On the initial visit, inclusion and exclusion criteria were
discussed, the consent form was reviewed and signed, history and
physical examination performed, photographs taken, and scalp and
body evaluation completed employing the Alopecia Areata Guide-
lines (Olsen et al., 2004).
If no contraindications to study participation were found, four
4-mm scalp biopsy specimens were taken from the right parietal
scalp. Two specimens were processed as a cell suspension for cell
activation studies. The remaining two specimens were used for
histopathology, one specimen was vertically and the other horizon-
tally sectioned. Both were stained using standard techniques. Biopsy
specimen sections were analyzed by a dermatopathologist (D.W.)
who was blinded to any patient information. Observations were
made for the upper follicle region (infundibulum and isthmus above
arrector pili muscle insertion) and lower follicle (below arrector pili
muscle insertion and including the hair bulb) on each patient’s bio-
psy specimen (see Steiner L.P. et al. (2002) Poster Presentation, Fourth
International Alopecia Areata Research Workshop, Washington, DC,
November). Healthy control subjects 18–40 years of age (three men,
three women) without clinical evidence of scalp erythema, scale, or
other inflammation were recruited to participate in this study, and also
gave two 4-mm scalp biopsy specimens from the right parietal scalp
for the flow cytometry studies.
Preparation of cell suspension and T-cell activation
Two 4-mm scalp biopsy specimens, including subcutaneous fat,
were immediately minced into o1 mm fragments, placed in 4 ml
of 10 mM N-2-hydroxyethylpiperazine-N0-2-ethanesulfonic acid-buf-
fered RPMI (Gibco, Carlsbad, CA) and 2 mg/ml collagenase (Sigma,
St Louis, MO), and incubated for 2 hours at 371C in 5% carbon
dioxide with constant agitation. Samples were vortexed at 1 hour of
incubation and at the end of incubation. The digest was passed
through a 70 mM cell strainer and rinsed with a 40 ml RPMI aliquot
containing 10% fetal bovine serum. Cells were washed twice in cold
RPMI with 10% fetal bovine serum and resuspended in 12 ml RPMI
plus 10% fetal bovine serum media. Cells were then divided into
a 4 ml aliquot, which was stored at 41C for 4 hours, and an 8 ml
aliquot, which was activated and stained for cytokine expression.
T-cells were activated with 1.5 mM ionomycin and 50ng/ml phorbol
12-myristate 13-acetate (Sigma, St Louis, MO) along with 6 ml
golgistop (Monesin, PharMingen, San Diego, CA) at 371C for 4 hours
in standard T-cell media (RPMI supplemented with 10% fetal bovine
serum and 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid).
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Flow cytometry
Resting control or activated cells were washed in T-cell media and
resuspended in standard flow buffer (Hank’s balanced saline, 0.02%
sodium azide, and 2% fetal bovine serum), blocked for at least
10 minutes with 1% human IgG and 5% mouse serum (Sigma,
St Louis, MO), and then stained with antibodies to cell surface
antigens (CD-3 perCP; Becton-Dickinson, Franklin Lakes, NJ; CD-4
FITC, CD-8 FITC, CD-69 phycoerythrin; Pharmingen, San Diego,
CA) or isotype controls. All staining was performed in flow buffer for
20 minutes. CD-4-stained cells to be analyzed for CD-69 expression
were then washed twice with flow buffer and set aside. Cells to
be analyzed for intracellular cytokine expression of IL-2, IFN-g, or
tumor necrosis factor a were washed, fixed, permeabilized, stained
with anti-cytokine antibodies or controls, and rinsed according to the
supplier’s protocols (Cytofix/Cytoperm plus-I kit, Pharmingen, San
Diego, CA). All cells were resuspended in an equal volume of flow
buffer for analysis on the Becton-Dickenson FACS Calibur dual laser
flow cytometer. Data analysis was performed using CellQuest
software (Becton-Dickinson, Franklin Lakes, NJ).
Immunohistochemical staining for IFN-c
Samples for immunohistochemical staining consisted of 4-mm
punch biopsy specimens from the parietal region from 10/12 study
patients with EAA and from five normal control subjects. These
biopsy specimens had been embedded in paraffin. Four-micrometer-
thick sections were prepared from these blocks and stained as
per the immunohistochemical staining protocol. Each slide was
heat-fixed and deparaffinized by incubation at 601C for 1 hour and
washed in xylene. Endogenous peroxidase activity was quenched by
washing in ethyl alochol with peroxide, followed by successive
washes of 100, 80, and 70% ethyl alochol for 5 minutes each. The
slides were rehydrated in water and then phosphate-buffered saline
prior to antigen retrieval using 2mg/ml proteinase K treatment for
10 minutes at room temperature. Slides were blocked for nonspecific
reactivity with TNB buffer (0.1 M Tris-HCl, pH 7.5, 0.15 M NaCl,
0.5% blocking reagent) (TSA-Indirect kit, NEN Life Science Products,
Boston, MA) with added 10% normal horse serum for 2 hours at
room temperature. Slides were incubated overnight at 41C
(16–20 hours) with the primary antibodies IFN-g (Santa Cruz
Biotechnology, Santa Cruz, CA) and goat IgG (isotype control)
prepared in TNBþ 10% normal horse serum. Slides were then
washed in phosphate-buffered salineþ Tween 20. Peroxidase
expression was achieved using the Vectastain Elite ABC kit and the
DAB substrate peroxidase kit (Vector Labs, Burlingame, CA) as per
the manufacturer’s protocol. Incubation times were approximately
30 minutes for the ABC kit and 10 minutes for the DAB kit. Slides
were then washed in water before staining with hematoxylin
followed by dehydration in successive washes of 70, 80, and
100% ethyl alochol, and a final wash in xylene before coverslipping
for analysis. Staining with the isotype control primary antibody
followed by the same secondary antibody was performed for all
biopsy specimen sections studied. The isotype control showed a
consistent lack of peroxidase activity, demonstrating the specificity
of the IFN-g antibody (data not shown).
Control sample preparation
A challenge in the analysis of our samples was determining proper
controls for both positive and negative expression of IFN-g.
We obtained paraffin-embedded sample tissues from the University
of Minnesota tissue procurement facility of human lymph nodes and
tonsils demonstrating hyperplasia by pathological analysis, as well as
isolated biopsies of lymph nodes that were determined to be normal.
IFN-g expression was inconsistent and variably expressed among
the samples with hyperplasia. Thus, we determined that lymphoid
hyperplasia of undetermined etiology was neither a consistent nor an
adequate positive control. Alternatively, we were able to visualize
a positive control for IFN-g expression from draining lymph nodes
isolated from rhesus macaque monkeys that had been intravaginally
inoculated with simian immunodeficiency virus. The lymph nodes
were isolated on days 3, 7, and 12 postviral inoculation, fixed with
Streks tissue fixative, and embedded in paraffin for sectioning and
immunohistochemical staining. For negative control comparison,
scalp biopsy specimens from five normal human control subjects
without EAA, other skin inflammatory diseases, or identifiable
inflammation were stained and analyzed in conjunction with the
study samples.
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